Profile
Graeme Roy Kaufman served as the Chief Financial Officer of CSL Ltd.
from 1984 to 1999.
He was also an Executive Director of Opthea Ltd.
from 2002 to 2007.
Kaufman held several non-executive chairman and director positions in various firms such as Bionomics Ltd., Paradigm Biopharmaceuticals Ltd., Anagenics Ltd., and Idt Australia Ltd.
He was also an Executive Vice President-Finance at Mesoblast Ltd.
Kaufman obtained his undergraduate degree and MBA from the University of Melbourne.
Former positions of Graeme Roy Kaufman
| Companies | Position | End |
|---|---|---|
| PARADIGM BIOPHARMACEUTICALS LIMITED | Chairman | 2020-06-23 |
| IDT AUSTRALIA LIMITED | Chairman | 2017-11-20 |
| BIONOMICS LIMITED | Chairman | 2016-11-07 |
| ANAGENICS LIMITED | Director/Board Member | 2015-06-29 |
| MESOBLAST LIMITED | Corporate Officer/Principal | 2012-12-31 |
Training of Graeme Roy Kaufman
| University of Melbourne | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| OPTHEA LIMITED | Health Technology |
| CSL LIMITED | Health Technology |
| ANAGENICS LIMITED | Consumer Non-Durables |
| BIONOMICS LIMITED | Health Technology |
| IDT AUSTRALIA LIMITED | Health Technology |
| PARADIGM BIOPHARMACEUTICALS LIMITED | Health Technology |
| MESOBLAST LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
- Stock Market
- Insiders
- Graeme Roy Kaufman